{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:43:56Z","timestamp":1795095836166,"version":"4.10.2"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973355"],"award-info":[{"award-number":["81973355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-022-00057-1","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T16:02:46Z","timestamp":1652112166000},"page":"445-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Metabolic characterization of hypertrophic cardiomyopathy in human heart"],"prefix":"10.1038","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-0523","authenticated-orcid":false,"given":"Wenmin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-524X","authenticated-orcid":false,"given":"Jizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-2978","authenticated-orcid":false,"given":"Ke","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-5810","authenticated-orcid":false,"given":"Meng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-3662","authenticated-orcid":false,"given":"Yizi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-4577","authenticated-orcid":false,"given":"Huanhuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-8073","authenticated-orcid":false,"given":"Minjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-2996","authenticated-orcid":false,"given":"Hengzhi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-554X","authenticated-orcid":false,"given":"Xufang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3103-8442","authenticated-orcid":false,"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0772-9123","authenticated-orcid":false,"given":"Tianshu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingsheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-9321","authenticated-orcid":false,"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-7750","authenticated-orcid":false,"given":"Zeping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron, B. J. Clinical course and management of hypertrophic cardiomyopathy. New Engl. J. Med. 379, 655\u2013668 (2018).","journal-title":"New Engl. J. Med."},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian, C., Ingles, J., Maron, M. S. & Maron, B. J. New perspectives on the prevalence of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 65, 1249\u20131254 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani, S. S. et al. Heart disease and stroke statistics 2021 update: a report from the American heart association. Circulation 143, e254\u2013e743 (2021).","journal-title":"Circulation"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron, B. J. & Maron, M. S. Hypertrophic cardiomyopathy. Lancet 381, 242\u2013255 (2013).","journal-title":"Lancet"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrcardio.2016.140","volume":"13","author":"S Sen-Chowdhry","year":"2016","unstructured":"Sen-Chowdhry, S., Jacoby, D., Moon, J. C. & McKenna, W. J. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nat. Rev. Cardiol. 13, 651\u2013675 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J. & Braunwald, E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res. 121, 749\u2013770 (2017).","journal-title":"Circ. Res."},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares, A. A. et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet. Med. 17, 880\u2013888 (2015).","journal-title":"Genet. Med."},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","volume":"9","author":"N Frey","year":"2011","unstructured":"Frey, N., Luedde, M. & Katus, H. A. Mechanisms of disease: hypertrophic cardiomyopathy. Nat. Rev. Cardiol. 9, 91\u2013100 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrcardio.2016.98","volume":"13","author":"JO Ormerod","year":"2016","unstructured":"Ormerod, J. O., Frenneaux, M. P. & Sherrid, M. V. Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy. Nat. Rev. Cardiol. 13, 677\u2013687 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.jacc.2019.01.061","volume":"73","author":"BJ Maron","year":"2019","unstructured":"Maron, B. J., Maron, M. S., Maron, B. A. & Loscalzo, J. Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 1978\u20131986 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.118.037264","volume":"139","author":"N Maurizi","year":"2019","unstructured":"Maurizi, N. et al. Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy. Circulation 139, 830\u2013833 (2019).","journal-title":"Circulation"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott, P. M. et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur. Heart J. 35, 2733\u20132779 (2014).","journal-title":"Eur. Heart J."},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.118.314642","volume":"124","author":"A Kurilshikov","year":"2019","unstructured":"Kurilshikov, A. et al. Gut microbial associations to plasma metabolites linked to cardiovascular phenotypes and risk. Circ. Res. 124, 1808\u20131820 (2019).","journal-title":"Circ. Res."},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/msb.2011.57","volume":"7","author":"G Nicholson","year":"2011","unstructured":"Nicholson, G. et al. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol. Syst. Biol. 7, 525 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cpt.1538","volume":"106","author":"H Pang","year":"2019","unstructured":"Pang, H., Jia, W. & Hu, Z. Emerging applications of metabolomics in clinical pharmacology. Clin. Pharmacol. Ther. 106, 544\u2013556 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"57_CR16","doi-asserted-by":"publisher","first-page":"107827","DOI":"10.1016\/j.pharmthera.2021.107827","volume":"224","author":"L Liang","year":"2021","unstructured":"Liang, L., Sun, F., Wang, H. & Hu, Z. Metabolomics, metabolic flux analysis and cancer pharmacology. Pharmacol. Ther. 224, 107827 (2021).","journal-title":"Pharmacol. Ther."},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov. 15, 473\u2013484 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.jacc.2016.09.972","volume":"68","author":"JR Ussher","year":"2016","unstructured":"Ussher, J. R., Elmariah, S., Gerszten, R. E. & Dyck, J. R. The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J. Am. Coll. Cardiol. 68, 2850\u20132870 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu, J. & Thompson, C. B. Metabolic regulation of cell growth and proliferation. Nat. Rev. Mol. Cell Biol. 20, 436\u2013450 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","volume":"165","author":"J Davis","year":"2016","unstructured":"Davis, J. et al. A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy. Cell 165, 1147\u20131159 (2016).","journal-title":"Cell"},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D., Jaswal, J. S. & Stanley, W. C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207\u2013258 (2010).","journal-title":"Physiol. Rev."},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"eaan2788","DOI":"10.1126\/science.aan2788","volume":"359","author":"F Madeo","year":"2018","unstructured":"Madeo, F., Eisenberg, T., Pietrocola, F. & Kroemer, G. Spermidine in health and disease. Science 359, eaan2788 (2018).","journal-title":"Science"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/sj.embor.embor914","volume":"4","author":"R Percudani","year":"2003","unstructured":"Percudani, R. & Peracchi, A. A genomic overview of pyridoxal-phosphate-dependent enzymes. EMBO Rep. 4, 850\u2013854 (2003).","journal-title":"EMBO Rep."},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","volume":"47","author":"AJ Marian","year":"2006","unstructured":"Marian, A. J., Senthil, V., Chen, S. N. & Lombardi, R. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. J. Am. Coll. Cardiol. 47, 827\u2013834 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","volume":"119","author":"R Lombardi","year":"2009","unstructured":"Lombardi, R. et al. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation 119, 1398\u20131407 (2009).","journal-title":"Circulation"},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb, A. A. & Hill, B. G. Metabolic coordination of physiological and pathological cardiac remodeling. Circ. Res. 123, 107\u2013128 (2018).","journal-title":"Circ. Res."},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff, J. & Tian, R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc. Res. 113, 411\u2013421 (2017).","journal-title":"Cardiovasc. Res."},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","volume":"126","author":"J Ritterhoff","year":"2020","unstructured":"Ritterhoff, J. et al. Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. Circ. Res. 126, 182\u2013196 (2020).","journal-title":"Circ. Res."},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.cell.2018.08.042","volume":"174","author":"KA Dyar","year":"2018","unstructured":"Dyar, K. A. et al. Atlas of circadian metabolism reveals system-wide coordination and communication between clocks. Cell 174, 1571\u20131585 (2018).","journal-title":"Cell"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1737","volume":"5","author":"E Gottlieb","year":"2005","unstructured":"Gottlieb, E. & Tomlinson, I. P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer 5, 857\u2013866 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"57_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","volume":"41","author":"M Hilvo","year":"2020","unstructured":"Hilvo, M. et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur. Heart J. 41, 371\u2013380 (2020).","journal-title":"Eur. Heart J."},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard, B. G. & Varbo, A. Triglycerides and cardiovascular disease. Lancet 384, 626\u2013635 (2014).","journal-title":"Lancet"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1172\/JCI63888","volume":"122","author":"SB Russo","year":"2012","unstructured":"Russo, S. B. et al. Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J. Clin. Invest. 122, 3919\u20133930 (2012).","journal-title":"J. Clin. Invest."},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm891","volume":"9","author":"S Haq","year":"2003","unstructured":"Haq, S. et al. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat. Med. 9, 944\u2013951 (2003).","journal-title":"Nat. Med."},{"key":"57_CR36","first-page":"e533","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen, S. R. et al. 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142, e533\u2013e557 (2020).","journal-title":"Circulation"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1161\/CIRCULATIONAHA.116.024171","volume":"136","author":"WA Heggermont","year":"2017","unstructured":"Heggermont, W. A. et al. Inhibition of MicroRNA-146a and overexpression of its target dihydrolipoyl succinyltransferase protect against pressure overload-induced cardiac hypertrophy and dysfunction. Circulation 136, 747\u2013761 (2017).","journal-title":"Circulation"},{"key":"57_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.121.054885","volume":"144","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. PKM1 exerts critical roles in cardiac remodeling under pressure overload in the heart. Circulation 144, 712\u2013727 (2021).","journal-title":"Circulation"},{"key":"57_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley, W. C., Recchia, F. A. & Lopaschuk, G. D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093\u20131129 (2005).","journal-title":"Physiol. Rev."},{"key":"57_CR40","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1073\/pnas.89.14.6452","volume":"89","author":"JM Huang","year":"1992","unstructured":"Huang, J. M., Xian, H. & Bacaner, M. Long-chain fatty acids activate calcium channels in ventricular myocytes. PNAS 89, 6452\u20136456 (1992).","journal-title":"PNAS"},{"key":"57_CR41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone, A. et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927\u2013963 (2015).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"57_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1734-1140(09)70091-X","volume":"61","author":"PP Dimitrow","year":"2009","unstructured":"Dimitrow, P. P., Undas, A., Wo\u0142kow, P., Tracz, W. & Dubiel, J. S. Enhanced oxidative stress in hypertrophic cardiomyopathy. Pharmacol. Rep. 61, 491\u2013495 (2009).","journal-title":"Pharmacol. Rep."},{"key":"57_CR43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah, R. W., Crown, S. B., Zhang, G. F., Shah, S. H. & Newgard, C. B. Cardiovascular metabolomics. Circ. Res. 122, 1238\u20131258 (2018).","journal-title":"Circ. Res."},{"key":"57_CR44","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/RES.0000000000000097","volume":"118","author":"H Taegtmeyer","year":"2016","unstructured":"Taegtmeyer, H. et al. Assessing cardiac metabolism: a scientific statement from the American Heart Association. Circ. Res. 118, 1659\u20131701 (2016).","journal-title":"Circ. Res."},{"key":"57_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","volume":"370","author":"D Murashige","year":"2020","unstructured":"Murashige, D. et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370, 364\u2013368 (2020).","journal-title":"Science"},{"key":"57_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/cvr\/cvr038","volume":"90","author":"V Lionetti","year":"2011","unstructured":"Lionetti, V., Stanley, W. C. & Recchia, F. A. Modulating fatty acid oxidation in heart failure. Cardiovasc. Res. 90, 202\u2013209 (2011).","journal-title":"Cardiovasc. Res."},{"key":"57_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo, A., Cantley, L. C. & Pandolfi, P. P. Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 13, 227\u2013232 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"57_CR48","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","volume":"122","author":"K Abozguia","year":"2010","unstructured":"Abozguia, K. et al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 122, 1562\u20131569 (2010).","journal-title":"Circulation"},{"key":"57_CR49","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1161\/01.CIR.0000034049.61181.F3","volume":"106","author":"R Liao","year":"2002","unstructured":"Liao, R. et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106, 2125\u20132131 (2002).","journal-title":"Circulation"},{"key":"57_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05362-7","volume":"9","author":"D Shao","year":"2018","unstructured":"Shao, D. et al. Glucose promotes cell growth by suppressing branched-chain amino acid degradation. Nat. Commun. 9, 2935 (2018).","journal-title":"Nat. Commun."},{"key":"57_CR51","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/cvr\/cvy063","volume":"114","author":"Y Umbarawan","year":"2018","unstructured":"Umbarawan, Y. et al. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice. Cardiovasc. Res. 114, 1132\u20131144 (2018).","journal-title":"Cardiovasc. Res."},{"key":"57_CR52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2007.06.044","volume":"130","author":"NS Rajasekaran","year":"2007","unstructured":"Rajasekaran, N. S. et al. Human \u03b1B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 130, 427\u2013439 (2007).","journal-title":"Cell"},{"key":"57_CR53","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2020.04.043","volume":"181","author":"K Contrepois","year":"2020","unstructured":"Contrepois, K. et al. Molecular choreography of acute exercise. Cell 181, 1112\u20131130 (2020).","journal-title":"Cell"},{"key":"57_CR54","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee, E. P. et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121, 1402\u20131411 (2011).","journal-title":"J. Clin. Invest."},{"key":"57_CR55","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann, C. et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129, 1821\u20131831 (2014).","journal-title":"Circulation"},{"key":"57_CR56","doi-asserted-by":"crossref","unstructured":"Schwartz, P. J. et al. Inherited cardiac arrhythmias. Nat. Rev. Dis. Primers. 6, 58 (2020).","DOI":"10.1038\/s41572-020-0188-7"},{"key":"57_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","volume":"33","author":"Y Gong","year":"2021","unstructured":"Gong, Y. et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab. 33, 51\u201364 (2021).","journal-title":"Cell Metab."},{"key":"57_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","volume":"29","author":"AA Hakimi","year":"2016","unstructured":"Hakimi, A. A. et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29, 104\u2013116 (2016).","journal-title":"Cancer Cell"},{"key":"57_CR59","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.110.954446","volume":"122","author":"AP Landstrom","year":"2010","unstructured":"Landstrom, A. P. & Ackerman, M. J. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. Circulation. 122, 2441\u20132449 (2010).","journal-title":"Circulation."},{"key":"57_CR60","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","volume":"58","author":"W Ball","year":"2011","unstructured":"Ball, W. et al. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J. Am. Coll. Cardiol. 58, 2313\u20132321 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57_CR61","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh, B. J. et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation 124, 2761\u20132796 (2011).","journal-title":"Circulation"},{"key":"57_CR62","doi-asserted-by":"publisher","first-page":"e018236","DOI":"10.1161\/JAHA.120.018236","volume":"10","author":"G Wu","year":"2021","unstructured":"Wu, G. et al. Variant spectrum of formin homology 2 domain-containing 3 gene in chinese patients with hypertrophic cardiomyopathy. J. Am. Heart Assoc. 10, e018236 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"57_CR63","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.144","volume":"16","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. Eur. J. Heart Fail. 16, 950\u2013957 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"57_CR64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"57_CR65","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1021\/ac500317c","volume":"86","author":"MH Sarafian","year":"2014","unstructured":"Sarafian, M. H. et al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography\u2013mass spectrometry. Anal. Chem. 86, 5766\u20135774 (2014).","journal-title":"Anal. Chem."},{"key":"57_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cmet.2018.06.005","volume":"28","author":"F Huang","year":"2018","unstructured":"Huang, F. et al. Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers. Cell Metab. 28, 369\u2013382 (2018).","journal-title":"Cell Metab."},{"key":"57_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21907-9","volume":"12","author":"N Xiao","year":"2021","unstructured":"Xiao, N. et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 12, 1618 (2021).","journal-title":"Nat. Commun."},{"key":"57_CR68","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/elps.201200601","volume":"34","author":"J Han","year":"2013","unstructured":"Han, J., Gagnon, S., Eckle, T. & Borchers, C. H. Metabolomic analysis of key central carbon metabolism carboxylic acids as their 3-nitrophenylhydrazones by UPLC\/ESI-MS. Electrophoresis 34, 2891\u20132900 (2013).","journal-title":"Electrophoresis"},{"key":"57_CR69","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.1021\/acs.analchem.1c00767","volume":"93","author":"X Meng","year":"2021","unstructured":"Meng, X. et al. Simultaneous 3-nitrophenylhydrazine derivatization strategy of carbonyl, carboxyl and phosphoryl submetabolome for LC\u2013MS\/MS-based targeted metabolomics with improved sensitivity and coverage. Anal. Chem. 93, 10075\u201310083 (2021).","journal-title":"Anal. Chem."},{"key":"57_CR70","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"57_CR71","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart, F., Gautier, B., Singh, A. & KA, L. C. mixOmics: an R package for \u2018omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"57_CR72","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"57_CR73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B Methodol. 58, 267\u2013288 (1996).","journal-title":"J. R. Stat. Soc. B Methodol."},{"key":"57_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"57_CR75","doi-asserted-by":"crossref","unstructured":"Ishwaran, H., Kogalur, U. B., Blackstone, E. H. & Lauer, M. S. Random survival forests. Ann. Appl. Stat. 2, 841-860 (2008).","DOI":"10.1214\/08-AOAS169"},{"key":"57_CR76","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"57_CR77","doi-asserted-by":"crossref","unstructured":"van Heesch, S. et al. The translational landscape of the human heart. Cell 178, 242\u2013260 (2019).","DOI":"10.1016\/j.cell.2019.05.010"},{"key":"57_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26685-y","volume":"12","author":"M Nie","year":"2021","unstructured":"Nie, M. et al. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nat. Commun. 12, 6479 (2021).","journal-title":"Nat. Commun."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00057-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:56:49Z","timestamp":1727153809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00057-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":78,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1038\/s44161-022-00057-1","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"19 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}